These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28506635)

  • 41. A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin.
    Kadam RU; Wilson IA
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4240-4245. PubMed ID: 29610325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level.
    Otterstrom JJ; Brandenburg B; Koldijk MH; Juraszek J; Tang C; Mashaghi S; Kwaks T; Goudsmit J; Vogels R; Friesen RH; van Oijen AM
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5143-8. PubMed ID: 25404330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural comparison of different antibodies interacting with parvovirus capsids.
    Hafenstein S; Bowman VD; Sun T; Nelson CD; Palermo LM; Chipman PR; Battisti AJ; Parrish CR; Rossmann MG
    J Virol; 2009 Jun; 83(11):5556-66. PubMed ID: 19321620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
    Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines.
    Lu Y; Welsh JP; Swartz JR
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):125-30. PubMed ID: 24344259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.
    Xu R; Ekiert DC; Krause JC; Hai R; Crowe JE; Wilson IA
    Science; 2010 Apr; 328(5976):357-60. PubMed ID: 20339031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.
    Venkatramani L; Bochkareva E; Lee JT; Gulati U; Graeme Laver W; Bochkarev A; Air GM
    J Mol Biol; 2006 Feb; 356(3):651-63. PubMed ID: 16384583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies.
    Harris AK; Meyerson JR; Matsuoka Y; Kuybeda O; Moran A; Bliss D; Das SR; Yewdell JW; Sapiro G; Subbarao K; Subramaniam S
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4592-7. PubMed ID: 23460696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines.
    Ndifon W; Wingreen NS; Levin SA
    Proc Natl Acad Sci U S A; 2009 May; 106(21):8701-6. PubMed ID: 19439657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A highly conserved neutralizing epitope on group 2 influenza A viruses.
    Ekiert DC; Friesen RH; Bhabha G; Kwaks T; Jongeneelen M; Yu W; Ophorst C; Cox F; Korse HJ; Brandenburg B; Vogels R; Brakenhoff JP; Kompier R; Koldijk MH; Cornelissen LA; Poon LL; Peiris M; Koudstaal W; Wilson IA; Goudsmit J
    Science; 2011 Aug; 333(6044):843-50. PubMed ID: 21737702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine.
    Bar-Peled Y; Huang J; Nuñez IA; Pierce SR; Ecker JW; Ross TM; Mousa JJ
    Vaccine; 2019 Sep; 37(41):6022-6029. PubMed ID: 31481254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages.
    Corbett KS; Moin SM; Yassine HM; Cagigi A; Kanekiyo M; Boyoglu-Barnum S; Myers SI; Tsybovsky Y; Wheatley AK; Schramm CA; Gillespie RA; Shi W; Wang L; Zhang Y; Andrews SF; Joyce MG; Crank MC; Douek DC; McDermott AB; Mascola JR; Graham BS; Boyington JC
    mBio; 2019 Feb; 10(1):. PubMed ID: 30808695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.
    Wyrzucki A; Dreyfus C; Kohler I; Steck M; Wilson IA; Hangartner L
    J Virol; 2014 Jun; 88(12):7083-92. PubMed ID: 24719426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein.
    Harshbarger W; Abeyrathne PD; Tian S; Huang Y; Chandramouli S; Bottomley MJ; Malito E
    MAbs; 2021; 13(1):1955812. PubMed ID: 34420474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer.
    Lee PS; Zhu X; Yu W; Wilson IA
    J Virol; 2015 Jul; 89(14):7417-20. PubMed ID: 25926650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.
    Huang Y; Owino SO; Crevar CJ; Carter DM; Ross TM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural Basis for the Broad, Antibody-Mediated Neutralization of H5N1 Influenza Virus.
    Lin Q; Li T; Chen Y; Lau SY; Wei M; Zhang Y; Zhang Z; Yao Q; Li J; Li Z; Wang D; Zheng Q; Yu H; Gu Y; Zhang J; Chen H; Li S; Xia N
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms.
    McCraw DM; Gallagher JR; Harris AK
    Clin Vaccine Immunol; 2016 Jun; 23(6):483-495. PubMed ID: 27074939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses.
    Tsibane T; Ekiert DC; Krause JC; Martinez O; Crowe JE; Wilson IA; Basler CF
    PLoS Pathog; 2012; 8(12):e1003067. PubMed ID: 23236279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
    He W; Tan GS; Mullarkey CE; Lee AJ; Lam MM; Krammer F; Henry C; Wilson PC; Ashkar AA; Palese P; Miller MS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11931-11936. PubMed ID: 27698132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.